Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension

This study has been suspended.

( Question raised by Ethics Committee )

First Received: May 8, 2007 Last Updated: October 22, 2008 History of Changes

Sponsored by:	Alcon Research
Information provided by:	Alcon Research
ClinicalTrials.gov Identifier:	NCT00471068

Purpose

To compare the efficacy and safety in patients treated with travoprost versus dorzolamide/timolol maleate combination in patients with open-angle glaucoma or ocular hypertension

Condition	Intervention	Phase
Open-Angle Glaucoma Ocular Hypertension	Drug: Travatan	Phase IV

Genetics Home Reference related topics: early-onset glaucoma

MedlinePlus related topics: Glaucoma High Blood Pressure

Drug Information available for: Cosopt Travoprost

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension

Further study details as provided by Alcon Research:

Primary Outcome Measures:

IOP [ Time Frame: Duration ]

Estimated Enrollment:	80
Study Start Date:	March 2007
Estimated Primary Completion Date:	May 2009 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patient with open-angle glaucoma or ocular hypertension

Exclusion Criteria:

By Age

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00471068

Locations

Portugal
Coimbra
Coimbra, Portugal, 3000354

Sponsors and Collaborators

Alcon Research

Investigators

Study Director:

Anna Grau

Alcon Research

More Information

No publications provided

Responsible Party:	Alcon ( Anna Grau )
Study ID Numbers:	EMD-05-03
Study First Received:	May 8, 2007
Last Updated:	October 22, 2008
ClinicalTrials.gov Identifier:	NCT00471068 History of Changes
Health Authority:	Infarmed:Portugal

Study placed in the following topic categories:

Glaucoma
Eye Diseases
Glaucoma, Open-Angle
Vascular Diseases
Cardiovascular Agents

Antihypertensive Agents
Travoprost
Hypertension
Ocular Hypertension

Additional relevant MeSH terms:

Glaucoma
Therapeutic Uses
Eye Diseases
Glaucoma, Open-Angle
Vascular Diseases
Cardiovascular Diseases

Cardiovascular Agents
Antihypertensive Agents
Pharmacologic Actions
Travoprost
Ocular Hypertension
Hypertension

ClinicalTrials.gov processed this record on May 07, 2009